Daniel S. Matloff

4.8k total citations · 2 hit papers
32 papers, 3.4k citations indexed

About

Daniel S. Matloff is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Daniel S. Matloff has authored 32 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Hepatology and 10 papers in Surgery. Recurrent topics in Daniel S. Matloff's work include Liver Disease Diagnosis and Treatment (18 papers), Liver Disease and Transplantation (14 papers) and Organ Transplantation Techniques and Outcomes (7 papers). Daniel S. Matloff is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Liver Disease and Transplantation (14 papers) and Organ Transplantation Techniques and Outcomes (7 papers). Daniel S. Matloff collaborates with scholars based in United States, Spain and United Kingdom. Daniel S. Matloff's co-authors include Guadalupe García–Tsao, Norman D. Grace, Roberto J. Groszmann, Jaime Bosch, David Patch, Andrew K. Burroughs, Juan Carlos García‐Pagán, Àngels Escorsell, Robert Makuch and Ramón Planas and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Daniel S. Matloff

32 papers receiving 3.3k citations

Hit Papers

Hepatic Venous Pressure Gradient Predicts Clinical Decomp... 2005 2026 2012 2019 2007 2005 250 500 750

Peers

Daniel S. Matloff
Anastasios A. Mihas United States
Kiran Bambha United States
Colin E. Atterbury United States
Joo Hyun Sohn South Korea
Daniel S. Matloff
Citations per year, relative to Daniel S. Matloff Daniel S. Matloff (= 1×) peers Salvador Augustín

Countries citing papers authored by Daniel S. Matloff

Since Specialization
Citations

This map shows the geographic impact of Daniel S. Matloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel S. Matloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel S. Matloff more than expected).

Fields of papers citing papers by Daniel S. Matloff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel S. Matloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel S. Matloff. The network helps show where Daniel S. Matloff may publish in the future.

Co-authorship network of co-authors of Daniel S. Matloff

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel S. Matloff. A scholar is included among the top collaborators of Daniel S. Matloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel S. Matloff. Daniel S. Matloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Combs, Daniel, et al.. (2023). The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome. Journal of Clinical Sleep Medicine. 19(12). 2065–2073. 6 indexed citations
2.
Matloff, Daniel S., et al.. (2019). Development Toward a Triple-Marker Biosensor for Diagnosing Cardiovascular Disease. Critical Reviews in Biomedical Engineering. 47(2). 169–178. 9 indexed citations
3.
Buck, Martina, Guadalupe García–Tsao, Roberto J. Groszmann, et al.. (2013). Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients. Hepatology. 59(3). 1052–1059. 57 indexed citations
4.
Berzigotti, Annalisa, Guadalupe García–Tsao, Jaime Bosch, et al.. (2011). Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 54(2). 555–561. 222 indexed citations
5.
Qamar, Amir, Norman D. Grace, Roberto J. Groszmann, et al.. (2009). Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis. Clinical Gastroenterology and Hepatology. 7(6). 689–695. 194 indexed citations
6.
Ripoll, Cristina, Roberto J. Groszmann, Guadalupe García–Tsao, et al.. (2009). Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. Journal of Hepatology. 50(5). 923–928. 295 indexed citations
7.
Qamar, Amir, Norman D. Grace, Roberto J. Groszmann, et al.. (2007). Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology. 47(1). 153–159. 110 indexed citations
8.
Ripoll, Cristina, Roberto J. Groszmann, Guadalupe García–Tsao, et al.. (2007). Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis. Gastroenterology. 133(2). 481–488. 787 indexed citations breakdown →
9.
Ripoll, Cristina, Roberto J. Groszmann, Norman D. Grace, et al.. (2007). CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT. 1 indexed citations
10.
Groszmann, Roberto J., Guadalupe García–Tsao, Jaime Bosch, et al.. (2005). Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis. New England Journal of Medicine. 353(21). 2254–2261. 645 indexed citations breakdown →
11.
Abraczinskas, Diane R., Rie Ookubo, Norman D. Grace, et al.. (2001). Propranolol for the prevention of first esophageal variceal hemorrhage: A lifetime commitment?. Hepatology. 34(6). 1096–1102. 88 indexed citations
12.
Matloff, Daniel S.. (1992). Therapy in liver diseases. Gastroenterology. 103(4). 1365–1365. 52 indexed citations
13.
Matloff, Daniel S.. (1992). TREATMENT OF ACUTE VARICEAL BLEEDING. Gastroenterology Clinics of North America. 21(1). 103–118. 21 indexed citations
14.
Conn, Harold O., Norman D. Grace, Jackie Bosch, et al.. (1991). Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. Hepatology. 13(5). 902–912. 164 indexed citations
15.
Grace, Norman D., Harold O. Conn, Robert H. Resnick, et al.. (1988). Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: A randomized controlled trial. Hepatology. 8(6). 1475–1481. 85 indexed citations
16.
Matloff, Daniel S., et al.. (1982). A Prospective Trial of D-Penicillamine in Primary Biliary Cirrhosis. New England Journal of Medicine. 306(6). 319–326. 97 indexed citations
17.
Kaplan, Marshall M., Michael J. Goldberg, Daniel S. Matloff, Robert M. Neer, & David B. P. Goodman. (1981). Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.. PubMed. 81(4). 681–5. 34 indexed citations
18.
Kaplan, Marshall M., Michael J. Goldberg, Daniel S. Matloff, Robert M. Neer, & David B. P. Goodman. (1981). Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis. Gastroenterology. 81(4). 681–685. 39 indexed citations
19.
Matloff, Daniel S., et al.. (1980). Effects of 25-OH vitamin D treatment on calcium metabolism and bone disease in primary biliary cirrhosis (PBC).. Gastroenterology. 78. 3 indexed citations
20.
Matloff, Daniel S. & Marshall M. Kaplan. (1980). d-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis—Successful treatment with plasmapheresis and immunosuppressives. Gastroenterology. 78(5). 1046–1049. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026